Browse By: Country ι Category ι Publisher ι Tag

Hepatitis A Global Clinical Trials Review, H1, 2012

Pages » 71
Published By » GlobalData
Price » $2500
In stock
View Report Details
Description

GlobalData's clinical trial report, Hepatitis A Global Clinical Trials Review, H1, 2012" provides data on the Hepatitis A clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis A. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis A. This report is built using data and information sourced from proprietary databases, primary ... Click here for more details


Actos (Type 2 Diabetes) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Actos (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Actos sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performa
Published Date: Oct 2011
Price: $2000
Aleglitazar (Type 2 Diabetes) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Aleglitazar (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Aleglitazar sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales per
Published Date: Oct 2011
Price: $2000
Amaryl (Type 2 Diabetes) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Amaryl (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Amaryl sales estimates for US, EU-5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales perfo
Published Date: Oct 2011
Price: $2000
Apidra (Type 2 Diabetes) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Apidra (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Apidra sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance d
Published Date: Oct 2011
Price: $2000
ASP1941 (Type 2 Diabetes) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, ASP1941 (Type 2 Diabetes) Analysis and Forecasts to 2020 provides ASP1941 sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance
Published Date: Oct 2011
Price: $2000
Avandia (Type 2 Diabetes) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avandia (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Avandia sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during
Published Date: Oct 2011
Price: $2000
Basen (Type 2 Diabetes) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Basen (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Basen sales estimates for Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during t
Published Date: Oct 2011
Price: $2000
BI 10773 (Type 2 Diabetes) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, BI 10773 (Type 2 Diabetes) Analysis and Forecasts to 2020 provides BI10773 sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales per
Published Date: Oct 2011
Price: $2000
Bydureon (Type 2 Diabetes) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Bydureon (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Bydureon sales estimates for US, Eu5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales pe
Published Date: Oct 2011
Price: $2000
Byetta (Type 2 Diabetes) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Byetta (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Byetta sales estimates for US, EU5 and Japan . In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales perfo
Published Date: Oct 2011
Price: $2000

 


 

Related News

Breast cancer patients can benefit from exercise
A study showed that exercise provides many benefits to breast cancer patients. It especially helps to speed up the recovery time for patients of breast cancer. However, the study showed that most women patients don’t follow exercise regularly. Following regular, moderate amount of exercise in a week can greatly help women affected by breast cancer. Exercising can help patients to recover faster after breast cancer. It can also help to prolong their life and live more healthily. But, most
Date: Jun 09

HTC Joins with Microsoft to Release Windows Based Smartphone Windows Phone 8X And 8S
HTC has decided to release two new Windows based handsets by early November. The Company has joined hands with Microsoft to introduce these handsets that are powered by Windows Phone 8 and are called Windows 8X and Windows 8S. The HTC 8S features include 512 MB memory and 1Ghz Core Qualcomm S4 chip, 5 megapixel autofocus camera with LED flash and 4GB onboard storage whereas the HTC 8X includes specifications of a Qualcomm S41.5 GHz dual core processor, 1 GB RAM, and 16 GB RAM. The 8X is more
Date: Sep 26

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795